19937 results

Five-year clinical and echocardiographic outcomes from the PARTNER 3 Low-Risk randomized trial

26 Oct 2023

Alex Sticchi provides his take on the 5-year outcomes from PARTNER 3 Low Risk which were presented by Martin B. Leon at TCT Congress 2023.

Author

Alessandro Sticchi

CLASP IID one-year outcomes - Transcatheter edge-to-edge repair systems for degenerative MR

27 Oct 2023

Alessandro Sticchi interviews Robert L. Smith & Firas Zahr about the CLASP IID Trial and Registry which they presented during the TCT Congress 2023 in San Francisco.

The PASCAL system proved effective in treating high-risk patients with symptomatic degenerative mitral regurgitation, meeting primary and secondary endpoints while improving...

Author

Alessandro Sticchi

Author

Firas Zahr

Author

Robert L. Smith

Four-Year Outcomes from the EVOLUT Low Risk Trial

26 Oct 2023

Dejan Milasinovic provides his take on the EVOLUT Low Risk trial, presented by Michael I. Reardon at TCT Congress 2023. 4-year results reveal a continuing trend towards lower combined rates of all-cause mortality and disabling stroke with TAVI compared with surgical aortic valve replacement (SAVR)

Author

Dejan Milasinovic

Concomitant left atrial appendage occlusion and transcatheter aortic valve replacement among patients with atrial fibrillation – The WATCH-TAVR Trial

26 Oct 2023

Panos Xaplanteris provides his take on WATCH-TAVR results which were presented by Samir R. Kapadia at TCT Congress 2023.

Safety and Efficacy of Left Atrial Appendage Occlusion at the Time of Transcatheter Aortic Valve Replacement - The WATCH TAVR Trial

Author

Panagiotis Xaplanteris

The JenaValve Trilogy™ heart valve system in high surgical risk patients with symptomatic, severe aortic regurgitation: The ALIGN AR Trial

25 Oct 2023

Nicola Ryan provides her take on the ALIGN AR trial which was presented by Vinod H. Thourani at TCT Congress 2023. The Align AR trial is a prospective single-arm investigation device exemption study assessing the safety and efficacy of the Trilogy transcatheter heart valve system in patients with...

Author

Nicola Ryan

Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Ballon with Conventional Ballon Angioplasty for In-Stent Restenosis (AGENT IDE)

27 Oct 2023

Mirvat Alasnag provides her take on the AGENT IDE trial which was presented by Robert W. Yeh at TCT Congress 2023. This pivotal randomized trial compares the safety and efficacy of the AGENT DCB to conventional balloon angioplasty in patients with ISR. It is the first...

Author

Mirvat Alasnag

T-PASS: Less than 1-month DAPT followed by ticagrelor monotherapy after DES Implantation for ACS

26 Oct 2023

Ali Nazmi Calik interviews Myeong-Ki Hong about the results of the T-Pass randomised trial which he presented during the #TCT Congress 2023 in San Francisco.

Author

Myeong-Ki Hong

Author

Ali Nazmi Calik

Naim Mridha

QLD, Australia

Shravan Rao

NYC, United States of America

Prem Ratan

Metropolitan City of Milan, Italy

Courtney Ream

GA, United States of America

Darijan Ribic

Oslo, Norway

Matti Riihiniemi

Oulu, Finland

Felix Rudolph

Bad Oeynhausen, Germany

Marco Ruozzi

Modena, Italy

Debora Russo

Province of Mantua, Italy

Gustavo Sá Mendes

Évora, Portugal

Kazuya Sakamoto

Tokyo, Japan

Luisa Salido

MADRID, Spain

Juan Pablo Sanchez-Luna

Valladolid, Spain